Marie E. Robert

Yale University — United States

Medicine · Health Sciences

45h-index7.3kcitations181works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(25), Microscopic Colitis(21), Gastrointestinal disorders and treatments(19), Liver Disease Diagnosis and Treatment(16), Gastric Cancer Management and Outcomes(15)

Publications181 total

T cell receptors for antigen on intraepithelial cytolytic T lymphocytes in celiac disease engage enterocyte HLA-E and HLA-B
Proceedings of the National Academy of Sciences·2026Open Access
Induction FOLFIRINOX and SBRT for borderline/locally advanced pancreatic cancer.
Journal of Clinical Oncology·2026
Abstract A100: Systemic targeting of therapeutic RNA into pancreatic tumors via an RNA-binding and cell-penetrating antibody
Cancer Research·2025
Abstract A004: Altered RNA splicing drives pancreatic cancer by mimicking chromosome deletions
Cancer Research·2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer
Science Translational Medicine·2025· 4 cited
Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas
2025Open Access
A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301).
Journal of Clinical Oncology·2025· 3 cited
The evolving role of liver biopsy: Current applications and future prospects
Hepatology Communications·2025· 10 citedOpen Access
Amalgamating Biosteering and Productivity Index Trend Analysis on the First Underbalanced Coiled Tubing Drilling (UBCTD) Injector Well in the Middle East to Improve Well Performance in Real-Time
2024· 3 cited
Between ‘NET’ and ‘CoGNET’: A biphasic Neuroendocrine-Gangliocytic tumor of the pancreas
Human Pathology Reports·2024Open Access
35 (PB023): A Multicenter, Open-label Phase 1/2 Study of TYRA 300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF301)
European Journal of Cancer·2024
Abstract PR-01: Systemic targeting of therapeutic RNA to pancreatic ductal adenocarcinoma via a novel, cell-penetrating, and nucleic acid-binding monoclonal antibody
Cancer Research·2024
Abstract PR-11: Altered mRNA splicing mimics chromosome loss and drives pancreatic cancer
Cancer Research·2024
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer
JAMA Oncology·2024· 25 citedOpen Access
L’adhésion à l’hormonothérapie adjuvante : un enjeu majeur dans la prise en charge du cancer du sein
Bulletin du Cancer·2024· 1 citedOpen Access
Spécificités de la prise en charge diagnostique du cancer du sein chez la femme jeune
Imagerie de la Femme·2024
Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2024· 6 cited
Opportunities for Improving Biopsy and Non–Biopsy-Based Diagnosis of Celiac Disease
Gastroenterology·2024· 10 cited
Abstract C075: Altered RNA splicing causes pancreatic cancer and exposes a therapeutic vulnerability
Cancer Research·2024
Abstract A072: Keratin 17-signature for stratification of chemotherapy in pancreatic adenocarcinoma
Cancer Research·2024
page 1 of 10Next →

Frequent Co-authors

Michael H. Nathanson(9), John R. Goldblum(6), Joel K. Greenson(5), Dhanpat Jain(5), Amitabh Srivastava(5), Harry R. Aslanian(4), Marian M. Haber(3), Laura W. Lamps(3), Gregory Y. Lauwers(3), Audrey J. Lazenby(3), David Lewin(3), Laura H. Tang(3), Reetesh K. Pai(3), Rish K. Pai(3), Rhonda K. Yantiss(3), Jittima Weerachayaphorn(3), Mateus T. Guerra(3), Warren D. Shlomchik(2), Jennifer M. McNiff(2), Jinli Liu(2)